Chronic Myeloid Leukemia

Not yet recruiting

• Conditions: Chronic myeloid leukemia, BCR/ABL-positive,

• Registration Number: CTRI/2021/08/035398
• Lead Sponsor: DRREETIKA RAMANATHAN

Brief Summary

Newly diagnosed andfollow up cases of CML under Department of General Medicine and medical oncology in Manipal will be included inthe study.

Demographicdetails,clinical,laboratory findings will be collected and entered in theproforma.

Patients will be categorized into various CML phasesbased on WHO criteria and stratified into risk scores based on prognostic scoring system.(SOKAL,HASFORD,EUTOS).

Clinico-hematologicalresponse of follow up patients will be assessed.(for 3-6 monthswhenever possible).

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-07-31
• Study Start: 2021-08-15

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• 1.Newly diagnosed cases of CML.
• 2.Follow up cases of CML.

Exclusion Criteria

• 1.Patients who are unwilling to give written informed consent.
• 2.Patients lost to follow up.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients will be categorized into various CML phases based on WHO criteria and stratified into risk Scores based on prognostic scoring system.	6 months

Secondary Outcome Measures

Name	Time	Method
Clinico-hematological response of follow up patients will be assessed.	(for 3-6 months whenever possible).

Trial Locations

Locations (1)

KASTURBA HOSPITAL; 🇮🇳 Udupi, KARNATAKA, India

KASTURBA HOSPITAL

🇮🇳Udupi, KARNATAKA, India

Reetika Ramanathan

Principal investigator

9980201069

reetikar7@gmail.com